Trial intelligence / Profile preview

Mycamine for IFD Prophylaxis in Pediatric Autologous HSCT

NCT01417169Phase 2Unknown

Sponsor
Seoul National University Hospital
Start
Aug 2011
Primary completion
Dec 2014
Countries
1
01

Overview

A Phase 2 trial of micafungin in invasive fungal disease (IFD), sponsored by Seoul National University Hospital. Status: unknown.

02

Drugs

micafungin
03

Conditions

invasive fungal disease (IFD)

Beyond the preview

Go deeper on NCT01417169.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01417169.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call